EP3283521

Lyfjasamtengingar sem innihalda mótefni gegn claudin 18.2

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    13.4.2016
  • EP published:
    15.11.2023
  • EP application number:
    16715583.7
  • Max expiry date:
    12.4.2036
  • Expiry date:
    12.4.2026
  • Next due date:
    30.4.2026
  • Title in English:
    DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2
  • Language of the patent:
    English

Timeline

Today
13.4.2016EP application
15.11.2023EP Publication
12.12.2023Translation submitted
15.1.2024Registration published
12.4.2026Expires

Owner

  • Name:
    Astellas Pharma Inc.
  • Address:
    5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP
  • Name:
    TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
  • Address:
    Freiligrathstrasse 12, 55131 Mainz, DE

Inventor

  • Name:
    SAHIN, Ugur
  • Address:
    55116 Mainz, DE
  • Name:
    TÜRECI, Özlem
  • Address:
    55116 Mainz, DE
  • Name:
    WALTER, Korden
  • Address:
    55291 Saulheim, DE
  • Name:
    KREUZBERG, Maria
  • Address:
    55131 Mainz, DE
  • Name:
    MITNACHT-KRAUS, Rita
  • Address:
    61169 Friedberg, DE
  • Name:
    LE GALL, Fabrice
  • Address:
    55122 Mainz, DE
  • Name:
    JACOBS, Stefan
  • Address:
    55128 Mainz, DE

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    PCT/EP2015/058206
  • Date:
    15.4.2015
  • Country:
    WO

Classification

  • Categories:
    C07K 16/28, C07K 16/30, A61K 47/68, A61P 35/00, A61K 31/40

Annual fees

Number

Paid

Expires

Payer

Number: 9

Paid: 19.3.2024

Expires: 12.4.2025

Payer: Árnason Faktor ehf.

Number: 10

Paid: 14.4.2025

Expires: 12.4.2026

Payer: Árnason Faktor ehf.

Upload documents